| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
AASDH
|
aminoadipate-semialdehyde dehydrogenase
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACAD10
|
acyl-CoA dehydrogenase family, member 10
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACSBG2
|
acyl-CoA synthetase bubblegum family member 2
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTL7A
|
actin-like 7A
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ACVR2B
|
activin A receptor, type IIB
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADGRA3
|
adhesion G protein-coupled receptor A3
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPTL5
|
angiopoietin-like 5
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARG1
|
arginase 1
|
|
ARG2
|
arginase 2
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARX
|
aristaless related homeobox
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATG9A
|
autophagy related 9A
|
|
ATG9B
|
autophagy related 9B
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN3
|
ataxin 3
|
|
B2M
|
beta-2-microglobulin
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAX
|
BCL2-associated X protein
|
|
BBS9
|
Bardet-Biedl syndrome 9
|
|
BCAN
|
brevican
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLMH
|
bleomycin hydrolase
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BSG
|
basigin (Ok blood group)
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C21ORF2
|
chromosome 21 open reading frame 2
|
|
C3
|
complement component 3
|
|
CA2
|
carbonic anhydrase II
|
|
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV3
|
caveolin 3
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD14
|
CD14 molecule
|
|
CD24
|
CD24 molecule
|
|
CD248
|
CD248 molecule, endosialin
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD68
|
CD68 molecule
|
|
CD69
|
CD69 molecule
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDHR5
|
cadherin-related family member 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CDX4
|
caudal type homeobox 4
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM20
|
carcinoembryonic antigen-related cell adhesion molecule 20
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAD
|
chondroadherin
|
|
CHAF1B
|
chromatin assembly factor 1, subunit B (p60)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CISH
|
cytokine inducible SH2-containing protein
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CLCA1
|
chloride channel accessory 1
|
|
CLN5
|
ceroid-lipofuscinosis, neuronal 5
|
|
CLOCK
|
clock circadian regulator
|
|
CMAHP
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
|
CNPY2
|
canopy FGF signaling regulator 2
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRBN
|
cereblon
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1
|
|
CSMD3
|
CUB and Sushi multiple domains 3
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
DAP3
|
death associated protein 3
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DCDC1
|
doublecortin domain containing 1
|
|
DCN
|
decorin
|
|
DCX
|
doublecortin
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DGKH
|
diacylglycerol kinase, eta
|
|
DHFR
|
dihydrofolate reductase
|
|
DHH
|
desert hedgehog
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DLX4
|
distal-less homeobox 4
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPPA3
|
developmental pluripotency associated 3
|
|
DRD5
|
dopamine receptor D5
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DYRK3
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3
|
|
EDN1
|
endothelin 1
|
|
EFNA2
|
ephrin-A2
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR3
|
early growth response 3
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPHA4
|
EPH receptor A4
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FA2H
|
fatty acid 2-hydroxylase
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBN1
|
fibrillin 1
|
|
FBXW12
|
F-box and WD repeat domain containing 12
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FEZF2
|
FEZ family zinc finger 2
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FH
|
fumarate hydratase
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO1
|
flavin containing monooxygenase 1
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXE1
|
forkhead box E1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXP3
|
forkhead box P3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FTO
|
fat mass and obesity associated
|
|
FZD5
|
frizzled class receptor 5
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
GAA
|
glucosidase, alpha; acid
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GATA4
|
GATA binding protein 4
|
|
GATA6
|
GATA binding protein 6
|
|
GBA
|
glucosidase, beta, acid
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GDF2
|
growth differentiation factor 2
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GFRA2
|
GDNF family receptor alpha 2
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GH2
|
growth hormone 2
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAS
|
GNAS complex locus
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRHL1
|
grainyhead-like 1 (Drosophila)
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GRXCR1
|
glutaredoxin, cysteine rich 1
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTDC1
|
glycosyltransferase-like domain containing 1
|
|
GUSB
|
glucuronidase, beta
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2
|
|
HAPLN4
|
hyaluronan and proteoglycan link protein 4
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HBD
|
hemoglobin, delta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBZ
|
hemoglobin, zeta
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC8
|
histone deacetylase 8
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIST1H3B
|
histone cluster 1, H3b
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB2
|
high mobility group box 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOPX
|
HOP homeobox
|
|
HOXA13
|
homeobox A13
|
|
HOXB4
|
homeobox B4
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HS3ST5
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 5
|
|
HSD3B7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
IBD5
|
inflammatory bowel disease 5
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IHH
|
indian hedgehog
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL33
|
interleukin 33
|
|
IL34
|
interleukin 34
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRG1
|
immunoresponsive 1 homolog (mouse)
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISL2
|
ISL LIM homeobox 2
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAD
|
integrin, alpha D
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB6
|
integrin, beta 6
|
|
IVL
|
involucrin
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUND
|
jun D proto-oncogene
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0319
|
KIAA0319
|
|
KIAA1549
|
KIAA1549
|
|
KIF14
|
kinesin family member 14
|
|
KIF5A
|
kinesin family member 5A
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT15
|
keratin 15, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
LAMA1
|
laminin, alpha 1
|
|
LCN2
|
lipocalin 2
|
|
LCRB
|
locus control region, beta
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEFTY2
|
left-right determination factor 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX1
|
LIM homeobox 1
|
|
LHX3
|
LIM homeobox 3
|
|
LHX8
|
LIM homeobox 8
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIN7A
|
lin-7 homolog A (C. elegans)
|
|
LIN7B
|
lin-7 homolog B (C. elegans)
|
|
LIN7C
|
lin-7 homolog C (C. elegans)
|
|
LINS
|
lines homolog (Drosophila)
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMO4
|
LIM domain only 4
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRTM3
|
leucine rich repeat transmembrane neuronal 3
|
|
LY86
|
lymphocyte antigen 86
|
|
LYST
|
lysosomal trafficking regulator
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGED1
|
melanoma antigen family D1
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDH1
|
malate dehydrogenase 1, NAD (soluble)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEFV
|
Mediterranean fever
|
|
MEIS1
|
Meis homeobox 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MEST
|
mesoderm specific transcript
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MID1
|
midline 1
|
|
MIDN
|
midnolin
|
|
MIR105-1
|
microRNA 105-1
|
|
MIR105-2
|
microRNA 105-2
|
|
MIR106B
|
microRNA 106b
|
|
MIR1225
|
microRNA 1225
|
|
MIR133B
|
microRNA 133b
|
|
MIR145
|
microRNA 145
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR184
|
microRNA 184
|
|
MIR1915
|
microRNA 1915
|
|
MIR208A
|
microRNA 208a
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR223
|
microRNA 223
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR7-2
|
microRNA 7-2
|
|
MIR7-3
|
microRNA 7-3
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MORC3
|
MORC family CW-type zinc finger 3
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSTN
|
myostatin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC1
|
myosin binding protein C, slow type
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NAT9
|
N-acetyltransferase 9 (GCN5-related, putative)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCS1
|
neuronal calcium sensor 1
|
|
NDRG2
|
NDRG family member 2
|
|
NEO1
|
neogenin 1
|
|
NES
|
nestin
|
|
NEUROG3
|
neurogenin 3
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NNAT
|
neuronatin
|
|
NOBOX
|
NOBOX oogenesis homeobox
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOVA2
|
neuro-oncological ventral antigen 2
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PANK2
|
pantothenate kinase 2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PAX8
|
paired box 8
|
|
PBK
|
PDZ binding kinase
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PEX10
|
peroxisomal biogenesis factor 10
|
|
PF4
|
platelet factor 4
|
|
PGR
|
progesterone receptor
|
|
PHACTR3
|
phosphatase and actin regulator 3
|
|
PHB
|
prohibitin
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1L2
|
polycystic kidney disease 1-like 2 (gene/pseudogene)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAU
|
plasminogen activator, urokinase
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPT1
|
palmitoyl-protein thioesterase 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM16
|
PR domain containing 16
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROK1
|
prokineticin 1
|
|
PROM1
|
prominin 1
|
|
PROM2
|
prominin 2
|
|
PROX1
|
prospero homeobox 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PSEN1
|
presenilin 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
QSOX2
|
quiescin Q6 sulfhydryl oxidase 2
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RARB
|
retinoic acid receptor, beta
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RBPMS2
|
RNA binding protein with multiple splicing 2
|
|
RELN
|
reelin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFPL4A
|
ret finger protein-like 4A
|
|
RFT1
|
RFT1 homolog (S. cerevisiae)
|
|
RGR
|
retinal G protein coupled receptor
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RTN4
|
reticulon 4
|
|
RTN4R
|
reticulon 4 receptor
|
|
RTN4RL1
|
reticulon 4 receptor-like 1
|
|
RTN4RL2
|
reticulon 4 receptor-like 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RYK
|
receptor-like tyrosine kinase
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100B
|
S100 calcium binding protein B
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SEPT9
|
septin 9
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD2
|
SET domain containing 2
|
|
SETX
|
senataxin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPA2
|
surfactant protein A2
|
|
SFTPD
|
surfactant protein D
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SIX1
|
SIX homeobox 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10
|
|
SLC22A25
|
solute carrier family 22, member 25
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
|
|
SLC7A3
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SLCO3A1
|
solute carrier organic anion transporter family, member 3A1
|
|
SLCO4A1
|
solute carrier organic anion transporter family, member 4A1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD7
|
SMAD family member 7
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOSTDC1
|
sclerostin domain containing 1
|
|
SOX1
|
SRY (sex determining region Y)-box 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP110
|
SP110 nuclear body protein
|
|
SPAST
|
spastin
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SPZ1
|
spermatogenic leucine zipper 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SSBP1
|
single-stranded DNA binding protein 1, mitochondrial
|
|
ST5
|
suppression of tumorigenicity 5
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK3
|
serine/threonine kinase 3
|
|
STMN1
|
stathmin 1
|
|
STXBP2
|
syntaxin binding protein 2
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SULF2
|
sulfatase 2
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYP
|
synaptophysin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBX4
|
T-box 4
|
|
TBX5
|
T-box 5
|
|
TCF4
|
transcription factor 4
|
|
TCN2
|
transcobalamin II
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
THBS2
|
thrombospondin 2
|
|
THBS3
|
thrombospondin 3
|
|
THPO
|
thrombopoietin
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THSD1
|
thrombospondin, type I, domain containing 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLL1
|
tolloid-like 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR8
|
toll-like receptor 8
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMEM18
|
transmembrane protein 18
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPO
|
thyroid peroxidase
|
|
TRD
|
T cell receptor delta locus
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPO
|
translocator protein (18kDa)
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
|
UBE2D1
|
ubiquitin-conjugating enzyme E2D 1
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UTF1
|
undifferentiated embryonic cell transcription factor 1
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VSX2
|
visual system homeobox 2
|
|
VWF
|
von Willebrand factor
|
|
WFIKKN1
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
ZBTB38
|
zinc finger and BTB domain containing 38
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP42
|
ZFP42 zinc finger protein
|
|
ZNF382
|
zinc finger protein 382
|
|
ZNF469
|
zinc finger protein 469
|